|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Sexually-Transmitted Infections (STIs) Genital Lesion Panel
Test Code38286
CPT Codes
87529 (x2), 87798
Includes
SureSwab®, Herpes Simplex Virus, Type 1 and 2 mRNA,TMA
Treponema pallidum DNA, Qualitative Real-Time PCR
Treponema pallidum DNA, Qualitative Real-Time PCR
Preferred Specimen
1 genital lesion swab collected in an Aptima® Multitest Transport Tube
Instructions
Swab any visible lesions. Withdraw the swab without touching the skin. Immediately place the swab into the Aptima® Multitest Transport Tube (orange label) so that the tip of the swab is visible below the tube label. Carefully break the swab shaft at the score line against the side of the tube and discard the top portion of the swab shaft. Tightly screw the cap onto the tube.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 21 days
Refrigerated: 28 days
Frozen: 30 days
Refrigerated: 28 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Transport tubes with 2 swabs • Transport tubes with non-Aptima® swabs • Swab submitted in viral transport media • Aptima® Unisex collection kit (white label)
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Monday-Saturday Morning
Report available: 4 Days
Report available: 4 Days
Reference Range
HSV 1 | Not Detected |
HSV 2 | Not Detected |
T. pallidum DNA, QL Real Time PCR | Not Detected |
Clinical Significance
Due to the overlapping and often confusing clinical presentation of herpetic and syphilitic lesions, a combined panel testing for herpes simplex and Treponema pallidum when a genital lesion is identified facilitates effective targeted therapy directed toward the appropriate pathogen.